Current biopharmaceutical potency testing methods are time consuming, labor intensive, and—on a sterile manufacturing line—a potential source of contamination, says the team behind a new ...

InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases ...

Several pharmaceutical industry groups and companies have criticized the US Food and Drug Administration’s (FDA) recent guidance on potency assurance strategies for cell and gene therapies (CGTs) ...